You can buy or sell ANIX and other stocks, options, ETFs, and crypto commission-free!
Anixa Biosciences, Inc. Common Stock, also called Anixa Biosciences, is harnessing the body's immune system in the fight against cancer. Read More Anixa is developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body's immune response to the presence of a malignancy. It is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. Anixa also continually examines emerging technologies in complementary or related fields for further development and commercialization. The company was founded on November 5, 1982 and is headquartered San Jose, CA.